Amgen Inc. financials
Key figures from Amgen Inc.'s filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $10.1B | $9.2B | +9.5% |
| Net income | $2.4B | $1.4B | +65.9% |
| Free cash flow | $3.5B | $1.9B | +82.6% |
| Gross margin | 72.0% | 67.2% | +4.8 pts |
| Operating margin | 35.0% | 28.9% | +6.0 pts |
| Net margin | 23.6% | 15.6% | +8.0 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $36.8B | $7.7B | 21.0% | $8.1B | $14.23 |
| FY Dec 2024 | $33.4B | $4.1B | 12.2% | $10.4B | $7.56 |
| FY Dec 2023 | $28.2B | $6.7B | 23.8% | $7.4B | $12.49 |
| FY Dec 2022 | $26.3B | $6.6B | 24.9% | $8.8B | $12.11 |
| FY Dec 2021 | $26.0B | $5.9B | 22.7% | $8.4B | $10.28 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.